Trends in dispensing and utilisation of sustained-release tapentadol in Australia.
Objectives Tapentadol is a µ-opioid agonist, moderate noradrenaline reuptake inhibitor (NRI) and very weak serotonin reuptake inhibitor. The sustained release (SR) formulation is indicated for relief of chronic moderate to severe pain. We examined utilisation trends and concordance with prescribing...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Swansea University
2022-08-01
|
| Serie: | International Journal of Population Data Science |
| Soggetti: | |
| Accesso online: | https://ijpds.org/article/view/1978 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|